Print Options
PrintThe Whole
Act
PrintThe Whole
Cross Heading
PrintThis
Section
only
Changes over time for: Section 2A
Llinell Amser Newidiadau
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are outstanding changes not yet made by the legislation.gov.uk editorial team to Human Fertilisation and Embryology Act 1990. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Changes to Legislation
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
[2AThird party agreementsU.K.
(1)For the purposes of this Act, a “third party agreement” is an agreement in writing between a person who holds a licence and another person which is made in accordance with any licence conditions imposed by the Authority for the purpose of securing compliance with the requirements of Article 24 of the first Directive (relations between tissue establishments and third parties) and under which the other person—
(a)procures, tests or processes gametes or embryos (or both), on behalf of the holder of the licence, or
(b)supplies to the holder of the licence any goods or services (including distribution services) which may affect the quality or safety of gametes or embryos.
[(1A)For the purposes of subsection (1), as it applies in relation to Great Britain, Article 24 of the first Directive is to be read subject to the modifications set out in paragraph 11A(8) of Schedule 3A.]
(2)In this Act—
“relevant third party premises”, in relation to a licence, means any premises (other than premises to which the licence relates)—
(a)
on which a third party procures, tests, processes or distributes gametes or embryos on behalf of any person in connection with activities carried out by that person under a licence, or
(b)
from which a third party provides any goods or services which may affect the quality or safety of gametes or embryos to any person in connection with activities carried out by that person under a licence;
“third party” means a person with whom a person who holds a licence has a third party agreement.
(3)References in this Act to the persons to whom a third party agreement applies are to—
(a)the third party,
(b)any person designated in the third party agreement as a person to whom the agreement applies, and
(c)any person acting under the direction of a third party or of any person so designated.]
Yn ôl i’r brig